推动医药产业创新 促进中医药发展

2016-02-15 中国政府网 中国政府网

李克强总理于2015年9月23日在洛阳考察河南科技大学第一附属医院新区医院对前来就医的几位城镇和农村居民是否都有医保,以及医药费报销额度和自费比例等情况进行询问。总理说,健康是幸福的基础,生命是平等的,无论是城镇居民、职工还是农民,人人都应享有医保服务。国务院总理李克强2月14日主持召开国务院常务会议,部署推动医药产业创新升级,更好服务惠民生稳增长;确定进一步促进中医药发展措施,发挥传统医学优势造

李克强总理于2015年9月23日在洛阳考察河南科技大学第一附属医院新区医院对前来就医的几位城镇和农村居民是否都有医保,以及医药费报销额度和自费比例等情况进行询问。总理说,健康是幸福的基础,生命是平等的,无论是城镇居民、职工还是农民,人人都应享有医保服务。

国务院总理李克强2月14日主持召开国务院常务会议,部署推动医药产业创新升级,更好服务惠民生稳增长;确定进一步促进中医药发展措施,发挥传统医学优势造福人民;决定开展服务贸易创新发展试点,推进外贸转型增强服务业竞争力。

会议指出,医药产业关系全民健康,市场需求巨大,在各国都是重要产业。结合医药卫生体制改革,加快我国医药产业发展,对于更好满足群众医疗保健需求、推进健康中国建设、释放经济增长潜力,意义重大。会议确定,一是瞄准群众急需,加强原研药、首仿药、中药、新型制剂、高端医疗器械等研发创新,加快肿瘤、糖尿病、心脑血管疾病等多发病和罕见病重大药物产业化。支持已获得专利的国产原研药和品牌仿制药开展国际注册认证。二是健全安全性评价和产品溯源体系,强化全过程质量监管,对标国际先进水平,实施药品、医疗器械标准提高行动,尤其要提高基本药物质量。探索实施产品质量安全强制商业保险。推进医药生产过程智能化和绿色改造。三是结合医疗、医保、医药联动改革,加快临床急需药物和医疗器械产品审评审批。完善财税、价格、政府采购等政策,探索利用产业基金等方式,支持医药产业化和新品推广。支持医药企业兼并重组,培育龙头企业,解决行业“小散乱”问题。四是建设遍及城乡的现代医药流通网络,逐步理顺药品耗材价格。搭建全国药品信息公共服务平台,公开价格、质量等信息,接受群众监督。

会议指出,传承中医药优势,发挥其独特作用,可以更好造福人类健康。会议确定,一要促进中医药和民族医药继承保护与挖掘,抢救濒临失传的珍稀与珍贵古籍文献,强化师承教育,大力培养中医药人才,提高中医药应急救治、防病治病能力。二要促进中西医结合,探索运用现代技术和产业模式加快中医药发展。加强重大疑难疾病、慢性病等中医药防治和新药研发。完善中医药标准体系,强化中药材资源保护利用和规范种养。三要放宽中医药服务准入,完善覆盖城乡的中医服务网络,保证社会办和政府办中医医疗机构在执业等方面享有同等权利。四要发展中医养生保健服务,促进中医药与健康养老、旅游文化等融合发展,推动“互联网+”中医医疗。五要加大中医药投入和政策扶持。在国家基本药物目录中增加中成药品种数量,更好发挥“保基本”作用。加强中医理念研究推广,扩大中医药国际贸易和传播普及。

会议认为,扩大开放是助推经济发展和升级的重要举措。在当前国际经济形势复杂严峻的情况下,更要坚持提高对外开放水平。在促进货物贸易发展的同时,加快服务贸易发展,可以推进外贸结构优化,培育经济新动能和带动就业。会议决定,用2年时间,在天津、上海、海南、深圳、杭州、武汉、广州、成都、苏州、威海10个省市和哈尔滨、江北、两江、贵安、西咸5个国家级新区开展服务贸易创新发展试点,重点对服务贸易管理体制、发展模式、便利化等8个方面的制度建设进行探索,有序扩大服务业开放准入。为此,要加大相关政策支持。一要在试点地区推广技术先进型服务企业税收优惠政策,将享受政策的企业范围由服务外包扩大到高技术、高附加值的其他服务行业,给予减按15%缴纳企业所得税的优惠,并对职工教育经费不超过工资薪金总额8%的部分据实税前扣除。二要设立服务贸易创新发展引导基金,为试点地区中小服务企业提供融资支持。对试点地区进口国内急需的研发设计、节能环保和环境服务给予财政贴息。三要鼓励金融机构创新供应链融资等业务,对试点地区经认定的技术先进型服务企业全面实施服务外包保税监管。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-17 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-16 jiangxianchen

    中医要火

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-16 zhuzhuba1

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-15 志琦

    中医,个人其实不看好,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-15 lietome1

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1993377, encodeId=a21219933e731, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Mar 28 01:34:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285244, encodeId=fef1128524433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408724, encodeId=915f1408e2417, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Feb 17 08:34:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64419, encodeId=4e4f6441984, content=中医要火, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Tue Feb 16 09:24:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64409, encodeId=6bda644090f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Tue Feb 16 07:33:00 CST 2016, time=2016-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64367, encodeId=a29b6436e98, content=中医,个人其实不看好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151031/IMG563499DA23B132080.jpg, createdBy=f7e51660024, createdName=志琦, createdTime=Mon Feb 15 20:20:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64348, encodeId=877a643486d, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64349, encodeId=c5b56434910, content=中国加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Mon Feb 15 19:39:00 CST 2016, time=2016-02-15, status=1, ipAttribution=)]
    2016-02-15 lietome1

    中国加油!

    0

相关资讯

上海中医药国际论坛,精彩视频集锦,阐述中医药未来发展趋势

中医药是我国独特的卫生资源、优秀的文化资源、有原创优势的科技资源、潜力巨大的经济资源、重要的生态资源。“上海中医药国际论坛”立足中国传统中医药学,发展现代中医科学,注重跨文化沟通与中医药服务贸易发展,邀请国内外医药领域权威专家做学术报告,旨在弘扬学术精神,推动中医药的国际传播,加速中医学科发展与多学科的交叉融合,促进学术研究与社会、经济生活的联系,为人们享有更健康美好的生活而努力。 上海中医

屠呦呦在诺奖报告会演讲:中医药学是一个伟大宝库

2015年诺贝尔生理学或医学奖得主,中国女药学家屠呦呦已经抵达瑞典并将于10日出席诺贝尔颁奖典礼。当地时间12月7日下午(北京时间7日晚),屠呦呦在卡罗琳医学院诺贝尔大厅用中文做题为《青蒿素的发现 中国传统医学对世界的礼物》的演讲,由翻译进行同声传译。屠呦呦在演讲中说:“中国医药学是一个伟大宝库,应当努力发掘,加以提高。”青蒿素正是从这一宝库中发掘出来的。通过抗疟药青蒿素的研究经历,深感中西医

李中赋:屠呦呦获奖带给我们的启示

■李中赋 科学家屠呦呦荣获2015年诺贝尔生理学或医学奖入选年度十大科技新闻。作为中国大陆获得的第一个诺贝尔科学奖,引发广泛关注和热议,在我国科技发展进程中具有重要的标志意义。它标志着中国本土科学家登上世界医学科技高峰,标志着中医药现代化的成果获得世界的公认、中医药走向世界并产生更大的国际影响力。无疑,这将有力地提振民族自信、激励科技创新。 中华民族聪明、勤劳、勇敢,为人类文明进步

国务院又发话,中医药真的要火爆了!!

昨日(2月14日),是西方的情人节,也是新年上班的第一天,在这温情又充满干劲的节日里,医药界同样传来一利好消息,中医药发展将迎来新的契机。国务院总理李克强2月14日主持召开国务院常务会议,部署推动医药产业创新升级,确定进一步促进中医药发展措施,中医药发展的步伐将不断加快。医药产业将继续升级会议指出,医药产业关系全民健康,市场需求巨大,在各国都是重要产业。结合医药卫生体制改革,加快我国医药产业发展,

中国首部中医药法草案初审 中医可通过考核获医师资格

12月21日,《中医药法(草案)》首次提请十二届全国人大常委会第十八次会议审议,这标志着我国第一部中医药领域的法律进入正式立法程序。草案顺应中医药特点和发展需要,就资格准入、人才培养、中医药服务等制度作出了规定。草案规定,中医服务人员由省级中医药主管部门根据中医药技术方法的安全风险组织开展分类考核,考核合格即获得医师资格,并可以以个人开业的方式从事医疗活动。同时,草案也对现行执业医师法、医疗机构管

中医药领域启动国家自然科学基金重大项目

16日,由成都中医药大学梁繁荣教授主持的国家自然科学基金“十二五”重大项目——“穴位的敏化研究”在成都启动,这是中医药领域首个国家自然科学基金重大项目。 据悉,该项目由成都中医药大学牵头,北京中医药大学、复旦大学、中国人民解放军第四军医大学、四川大学联合承担,是中医药领域首个获得立项资助的国家自然科学基金重大项目。项目研究目标是揭示穴位敏化在不同病症发生、发展、转归的时空动态规律,为